Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
QuintilesIMS
Boehringer Ingelheim
Covington
Cipla
Citi

Generated: May 26, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077203

« Back to Dashboard

NDA 077203 describes CHOLESTYRAMINE LIGHT, which is a drug marketed by Par Pharm, Sandoz, Teva, Teva Pharms, and Zydus Pharms Usa Inc, and is included in five NDAs. It is available from five suppliers. Additional details are available on the CHOLESTYRAMINE LIGHT profile page.

The generic ingredient in CHOLESTYRAMINE LIGHT is cholestyramine. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.
Summary for 077203
Tradename:CHOLESTYRAMINE LIGHT
Applicant:Par Pharm
Ingredient:cholestyramine
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 077203
Mechanism of ActionBile-acid Binding Activity
Suppliers and Packaging for NDA: 077203
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 077203 ANDA Par Pharmaceutical, Inc. 49884-466 49884-466-65 60 PACKET in 1 CARTON (49884-466-65) > 5 g in 1 PACKET (49884-466-63)
CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 077203 ANDA Par Pharmaceutical, Inc. 49884-466 49884-466-67 210 g in 1 CAN (49884-466-67)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;ORALStrengthEQ 4GM RESIN/PACKET
Approval Date:Aug 26, 2005TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:POWDER;ORALStrengthEQ 4GM RESIN/SCOOPFUL
Approval Date:Aug 26, 2005TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Medtronic
Colorcon
Daiichi Sankyo
Chinese Patent Office
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.